207 related articles for article (PubMed ID: 33748727)
1. Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation.
Burton A; Tataru D; Driver RJ; Bird TG; Huws D; Wallace D; Cross TJS; Rowe IA; Alexander G; Marshall A;
JHEP Rep; 2021 Apr; 3(2):100232. PubMed ID: 33748727
[TBL] [Abstract][Full Text] [Related]
2. Global, regionalĀ and national burden of primary liver cancer by subtype.
Rumgay H; Ferlay J; de Martel C; Georges D; Ibrahim AS; Zheng R; Wei W; Lemmens VEPP; Soerjomataram I
Eur J Cancer; 2022 Jan; 161():108-118. PubMed ID: 34942552
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
4. Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.
Ladep NG; Khan SA; Crossey MM; Thillainayagam AV; Taylor-Robinson SD; Toledano MB
World J Gastroenterol; 2014 Feb; 20(6):1544-53. PubMed ID: 24587630
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
6. Time and deprivation trends in incidence of primary liver cancer subtypes in England.
Konfortion J; Coupland VH; Kocher HM; Allum W; Grocock MJ; Jack RH
J Eval Clin Pract; 2014 Aug; 20(4):498-504. PubMed ID: 24902884
[TBL] [Abstract][Full Text] [Related]
7. Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database.
Liao W; Coupland CAC; Innes H; Jepsen P; Matthews PC; Campbell C; ; Barnes E; Hippisley-Cox J
EClinicalMedicine; 2023 May; 59():101969. PubMed ID: 37200996
[TBL] [Abstract][Full Text] [Related]
8. Rising incidence of primary liver cancer in Brunei Darussalam.
Chong RJ; Abdullah MS; Hossain MM; Telisinghe PU; Chong VH
Asian Pac J Cancer Prev; 2013; 14(6):3473-7. PubMed ID: 23886131
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries.
An L; Zheng R; Zhang S; Chen R; Wang S; Sun K; Lu L; Zhang X; Zhao H; Zeng H; Wei W; He J
Hepatobiliary Surg Nutr; 2023 Feb; 12(1):45-55. PubMed ID: 36860251
[TBL] [Abstract][Full Text] [Related]
10. Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database.
Yao Z; Dai C; Yang J; Xu M; Meng H; Hu X; Lin N
J Gastrointest Oncol; 2023 Feb; 14(1):312-324. PubMed ID: 36915450
[TBL] [Abstract][Full Text] [Related]
11. Trends in Liver Cancer Incidence and Survival in Italy by Histologic Type, 2003-2017.
Mancini S; Bucchi L; Zamagni F; Guzzinati S; Dal Maso L; Rugge M; Bisceglia L; Serraino D; Casella C; Caldarella A; Falcini F; Musolino A; Carrozzi G; Rizzello RV; Mangone L; Mazzoleni G; Seghini P; Ferretti S; The Italian Cancer Registries' Collaborative Group
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551647
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades.
Abboud Y; Ismail M; Khan H; Medina-Morales E; Alsakarneh S; Jaber F; Pyrsopoulos NT
J Clin Transl Hepatol; 2024 Feb; 12(2):172-181. PubMed ID: 38343612
[TBL] [Abstract][Full Text] [Related]
13. NAFLD and MAFLD as emerging causes of HCC: A populational study.
Myers S; Neyroud-Caspar I; Spahr L; Gkouvatsos K; Fournier E; Giostra E; Magini G; Frossard JL; Bascaron ME; Vernaz N; Zampaglione L; Negro F; Goossens N
JHEP Rep; 2021 Apr; 3(2):100231. PubMed ID: 33748726
[TBL] [Abstract][Full Text] [Related]
14. Among Medicare Patients With Hepatocellular Carcinoma, Non-alcoholic Fatty Liver Disease is the Most Common Etiology and Cause of Mortality.
Hester D; Golabi P; Paik J; Younossi I; Mishra A; Younossi ZM
J Clin Gastroenterol; 2020; 54(5):459-467. PubMed ID: 30672817
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
[TBL] [Abstract][Full Text] [Related]
16. Trends in Incidence and Mortality of Primary Liver Cancer in Lithuania 1998-2015.
Dulskas A; Kavaliauskas P; Zagminas K; Jancoriene L; Smailyte G
Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33572744
[No Abstract] [Full Text] [Related]
17. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
18. Incidence, mortality, and survival of liver cancer using Korea central cancer registry database: 1999-2019.
Hong SY; Kang MJ; Kim T; Jung KW; Kim BW
Ann Hepatobiliary Pancreat Surg; 2022 Aug; 26(3):211-219. PubMed ID: 35934831
[TBL] [Abstract][Full Text] [Related]
19. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus Infection and the Temporal Trends in the Risk of Liver Cancer: A National Register-Based Cohort Study in Sweden.
Batyrbekova N; Aleman S; Lybeck C; Montgomery S; Duberg AS
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):63-70. PubMed ID: 31719064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]